Towards eliminating minimal residual disease in ovarian cancer to prevent recurrence
Abstract:
Over the last decade, our research provides strong evidence that the drivers of minimal residual disease (MRD) survival are different from those that drive bulk ovarian cancer. Therefore, eliminating minimal residual disease at the end of traditional treatment requires rationalised therapeutics that specifically target MRD drivers. In this talk I will discuss our recent work in characterising MRD in ovarian cancer and our ongoing work to develop therapeutics to eliminate it.
Date:
7 November 2023, 13:00 (Tuesday, 5th week, Michaelmas 2023)
Venue:
This event is hybrid
Speaker:
Professor Ahmed Ahmed (University of Oxford )
Organising department:
Nuffield Department of Women's and Reproductive Health
Organisers:
Michael Suttie (NDWRH, University of Oxford),
Dr Lydia Coxon (NDWRH, University of Oxford)
Organiser contact email address:
seminars@wrh.ox.ac.uk
Booking required?:
Recommended
Booking email:
seminars@wrh.ox.ac.uk
Audience:
Members of the University only
Editor:
Isobel Way
